Cytoreductive therapy in younger adults with polycythemia vera: a meta-analysis of safety and outcomes
Abstract Cytoreductive therapy is not routinely recommended for younger patients with polycythemia vera (PV) due to concern that treatment toxicity may outweigh therapeutic benefits. However, no systematic data support this approach. To support objective risk/benefit assessment of cytoreductive drug...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Revisão |
| Langue: | anglais |
| Publié: |
2024
|
| Accès en ligne: | https://doi.org/10.1182/bloodadvances.2023012459 https://ashpublications.org/bloodadvances/article-pdf/doi/10.1182/bloodadvances.2023012459/2218804/bloodadvances.2023012459.pdf |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|